065170 — BL PharmTech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Market Cap
KR₩62bn
Enterprise Value
KR₩60bn
Revenue
KR₩7bn

Annual balance sheet for BL PharmTech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	22,752	5,524	10,687	3,864	7,151
Net Total Accounts Receivable
Net Total Receivables	11,182	11,143	1,104	1,039	847
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	42,301	32,612	16,915	6,937	8,584
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	42,899	42,339	2,878	4,129	3,808
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	130,341	103,687	44,802	36,458	18,195
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	37,000	48,979	7,965	6,629	8,994
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	71,845	69,886	13,383	12,211	10,299
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	58,497	33,800	31,419	24,247	7,896
Total Liabilities & Shareholders' Equity	130,341	103,687	44,802	36,458	18,195
Total Common Shares Outstanding